S100B as a glial cell marker in diabetic peripheral neuropathy

Neuroscience Letters

Volumn 558, Issue , 2014, Pages 53-57

  Celikbilek, Asuman ^a   Akyol, Lutfi ^a   Sabah, Seda ^a   Tanik, Nermin ^a   Adam, Mehmet ^a   Celikbilek, Mehmet ^a   Korkmaz, Murat ^a   Yilmaz, Neziha ^a  

^a BOZOK UNIVERSITY   (Turkey)

Author keywords

Diabetes; Diabetic peripheral neuropathy; GFAP; S100B

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; HEMOGLOBIN A1C; PROTEIN S100B;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL STUDY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIET RESTRICTION; DISEASE DURATION; ELISA KIT; FEMALE; GLIA CELL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ASSESSMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

DIABETES; DIABETIC PERIPHERAL NEUROPATHY; GFAP; S100B;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MIDDLE AGED; NEUROGLIA; PROSPECTIVE STUDIES; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT;

EID: 84888395947     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.10.067     Document Type: Article

References (31)

1. A.American Diabetes Diagnosis and classification of diabetes mellitus. Diabetes Care 2009, 32(Suppl. 1):S62-67.
2. Anderson R.E., Hansson L.O., Nilsson O., Liska J., Settergren G., Vaage J. Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources. The Annals of Thoracic Surgery 2001, 71:1512-1517.
3. Barger S.W., Van Eldik L.J., Mattson M.P. S100 beta protects hippocampal neurons from damage induced by glucose deprivation. Brain Research 1995, 677:167-170.
4. Baydas G., Donder E., Kiliboz M., Sonkaya E., Tuzcu M., Yasar A., Nedzvetskii V.S. Neuroprotection by alpha-lipoic acid in streptozotocin-induced diabetes. Biochemistry/Biokhimiia 2004, 69:1001-1005.
5. Baydas G., Nedzvetskii V.S., Tuzcu M., Yasar A., Kirichenko S.V. Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. European Journal of Pharmacology 2003, 462:67-71.
6. Baydas G., Reiter R.J., Nedzvetskii V.S., Nerush P.A., Kirichenko S.V. Altered glial fibrillary acidic protein content and its degradation in the hippocampus, cortex and cerebellum of rats exposed to constant light: reversal by melatonin. Journal of Pineal Research 2002, 33:134-139.
7. Baydas G., Reiter R.J., Yasar A., Tuzcu M., Akdemir I., Nedzvetskii V.S. Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free Radical Biology & Medicine 2003, 35:797-804.
8. Baydas G., Tuzcu M., Yasar A., Baydas B. Early changes in glial reactivity and lipid peroxidation in diabetic rat retina: effects of melatonin. Acta Diabetologica 2004, 41:123-128.
9. Bouhassira D., Attal N., Alchaar H., Boureau F., Brochet B., Bruxelle J., Cunin G., Fermanian J., Ginies P., Grun-Overdyking A., Jafari-Schluep H., Lanteri-Minet M., Laurent B., Mick G., Serrie A., Valade D., Vicaut E. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005, 114:29-36.
10. Chandy A., Pawar B., John M., Isaac R. Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2008, 19:924-928.
11. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. The International Journal of Biochemistry & Cell Biology 2001, 33:637-668.
12. Girach A., Manner D., Porta M. Diabetic microvascular complications: can patients at risk be identified? A review. International Journal of Clinical Practice 2006, 60:1471-1483.
13. Herrmann M., Vos P., Wunderlich M.T., de Bruijn C.H., Lamers K.J. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke; A Journal of Cerebral Circulation 2000, 31:2670-2677.
14. Lara D.R., Gama C.S., Belmonte-de-Abreu P., Portela L.V., Goncalves C.A., Fonseca M., Hauck S., Souza D.O. Increased serum S100B protein in schizophrenia: a study in medication-free patients. Journal of Psychiatric Research 2001, 35:11-14.
15. Liedtke W., Edelmann W., Bieri P.L., Chiu F.C., Cowan N.J., Kucherlapati R., Raine C.S. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 1996, 17:607-615.
16. Low P.A., Nickander K.K., Tritschler H.J. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997, 46(Suppl. 2):S38-S42.
17. Moghtaderi A., Bakhshipour A., Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clinical Neurology and Neurosurgery 2006, 108:477-481.
18. Mohammadzadeh F., Desjardins J.F., Tsoporis J.N., Proteau G., Leong-Poi H., Parker T.G. S100B: role in cardiac remodeling and function following myocardial infarction in diabetes. Life Sciences 2013, 92:639-647.
19. Portela L.V., Brenol J.C., Walz R., Bianchin M., Tort A.B., Canabarro U.P., Beheregaray S., Marasca J.A., Xavier R.M., Neto E.C., Goncalves C.A., Souza D.O. Serum S100B levels in patients with lupus erythematosus: preliminary observation. Clinical and Diagnostic Laboratory Immunology 2002, 9:164-166.
20. Raabe A., Grolms C., Sorge O., Zimmermann M., Seifert V. Serum S-100B protein in severe head injury. Neurosurgery 1999, 45:477-483.
21. Rong L.L., Yan S.F., Wendt T., Hans D., Pachydaki S., Bucciarelli L.G., Adebayo A., Qu W., Lu Y., Kostov K., Lalla E., Yan S.D., Gooch C., Szabolcs M., Trojaborg W., Hays A.P., Schmidt A.M. RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways. FASEB Journal 2004, 18:1818-1825.
22. Rosen P., Nawroth P.P., King G., Moller W., Tritschler H.J., Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes/Metabolism Research and Reviews 2001, 17:189-212.
23. Russell J.W., Golovoy D., Vincent A.M., Mahendru P., Olzmann J.A., Mentzer A., Feldman E.L. High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB Journal 2002, 16:1738-1748.
24. Schaf D.V., Tort A.B., Fricke D., Schestatsky P., Portela L.V., Souza D.O., Rieder C.R. S100B and NSE serum levels in patients with Parkinson's disease. Parkinsonism & Related Disorders 2005, 11:39-43.
25. Schmeichel A.M., Schmelzer J.D., Low P.A. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 2003, 52:165-171.
26. Singleton J.R., Smith A.G., Bromberg M.B. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001, 24:1448-1453.
27. Sorci G., Riuzzi F., Arcuri C., Tubaro C., Bianchi R., Giambanco I., Donato R. S100B protein in tissue development, repair and regeneration. World Journal of Biological Chemistry 2013, 4:1-12.
28. van Geel W.J., de Reus H.P., Nijzing H., Verbeek M.M., Vos P.E., Lamers K.J. Measurement of glial fibrillary acidic protein in blood: an analytical method. Clinica Chimica Acta; International Journal of Clinical Chemistry 2002, 326:151-154.
29. Vincent A.M., Russell J.W., Low P., Feldman E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocrine Reviews 2004, 25:612-628.
30. Vos P.E., Jacobs B., Andriessen T.M., Lamers K.J., Borm G.F., Beems T., Edwards M., Rosmalen C.F., Vissers J.L. GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology 2010, 75:1786-1793.
31. Yilmaz N., Karaali K., Ozdem S., Turkay M., Unal A., Dora B. Elevated S100B and neuron specific enolase levels in patients with migraine-without aura: evidence for neurodegeneration?. Cellular and Molecular Neurobiology 2011, 31:579-585.